Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Bafna Pharmaceuticals Board Meeting Date

Bafna Pharmaceuticals has scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Source

BSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bafna Pharmaceuticals Ltd: key numbers

Share price
₹451.60
Market cap
₹1,068 Cr
Revenue (annual)
₹150.6 Cr
Net profit (annual)
₹11.10 Cr
P/E (TTM)
137.2×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bafna Pharmaceuticals Ltd

All →

Other board meeting date announcements

All →